المؤلفون: Bataller A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bazinet A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Patel K; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Tang G; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Alvarado Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Maiti A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Abbas HA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. fravandi@mdanderson.org.

المصدر: Haematologica [Haematologica] 2024 May 02. Date of Electronic Publication: 2024 May 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

المؤلفون: Cieniewicz B; CERo Therapeutics Inc., South San Francisco, California., Oliveira E; CERo Therapeutics Inc., South San Francisco, California., Saxton M; CERo Therapeutics Inc., South San Francisco, California., Torabi D; CERo Therapeutics Inc., South San Francisco, California., Bhatta A; CERo Therapeutics Inc., South San Francisco, California., Kukutla P; CERo Therapeutics Inc., South San Francisco, California., Arballo A; CERo Therapeutics Inc., South San Francisco, California., Yang Z; CERo Therapeutics Inc., South San Francisco, California., Yu B; CERo Therapeutics Inc., South San Francisco, California., Fate M; CERo Therapeutics Inc., South San Francisco, California., Ning H; CERo Therapeutics Inc., South San Francisco, California., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Maiti A; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas., Corey D; CERo Therapeutics Inc., South San Francisco, California.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 01; Vol. 30 (9), pp. 1878-1888.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/therapy , Leukemia, Myeloid, Acute*/pathology , Leukemia, Myeloid, Acute*/immunology , Leukemia, Myeloid, Acute*/metabolism , T-Lymphocytes*/immunology , T-Lymphocytes*/metabolism , Membrane Proteins*/genetics , Membrane Proteins*/metabolism, Humans ; Mice ; Animals ; Cell Line, Tumor ; Xenograft Model Antitumor Assays ; Female ; Male ; Middle Aged ; Adult ; Aged ; Immunotherapy, Adoptive/methods

المؤلفون: Gruszczynska A; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110., Maiti A; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas 77030., Miller CA; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110., Ramakrishnan SM; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110., Link DC; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110., Uy GL; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110., Petti AA; Department of Neurosurgery, Washington University School of Medicine, St. Louis, Missouri 63110., Hayes K; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas 77030., DiNardo CD; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas 77030., Ravandi F; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas 77030., Ley TJ; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110., Spencer DH; Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110., Gao F; Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, Missouri 63110., Konopleva MY; Albert Einstein College of Medicine, Bronx, New York 10461., Welch JS; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110; A2 Biotherapeutics, Agoura Hills, California 91301 (work completed while at Washington University). jwelch@a2biotherapeutics.com.

المصدر: Haematologica [Haematologica] 2024 Apr 11. Date of Electronic Publication: 2024 Apr 11.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

المؤلفون: Bataller A; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., DiNardo CD; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Bazinet A; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Daver NG; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Maiti A; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Borthakur G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Short N; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sasaki K; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jabbour EJ; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Issa GC; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pemmaraju N; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yilmaz M; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Montalban-Bravo G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Loghavi S; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ravandi F; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kantarjian HM; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Kadia TM; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

المصدر: American journal of hematology [Am J Hematol] 2024 Apr; Vol. 99 (4), pp. 792-796. Date of Electronic Publication: 2024 Feb 15.

نوع المنشور: Letter

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/epidemiology, Humans

المؤلفون: Bazinet A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Short N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Alvarado Y; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Bataller A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Abuasab T; Department of Internal Medicine, Section of Hematology, Baylor College of Medicine, Houston, TX, USA., Islam R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Montalbano K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Issa G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Maiti A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jain N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Masarova L; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kornblau S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rausch CR; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kadia T; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Konopleva M; Department of Oncology, Albert Einstein College of Medicine, Bronx, NY, USA., Huang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: fravandi@mdanderson.org.

المصدر: The Lancet. Haematology [Lancet Haematol] 2024 Apr; Vol. 11 (4), pp. e276-e286. Date of Electronic Publication: 2024 Mar 04.

نوع المنشور: Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101643584 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3026 (Electronic) Linking ISSN: 23523026 NLM ISO Abbreviation: Lancet Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/diagnosis , Respiratory Insufficiency*/chemically induced , Respiratory Insufficiency*/drug therapy , Sepsis*/chemically induced , Sepsis*/drug therapy , Drug Combinations* , Sulfonamides* , Bridged Bicyclo Compounds, Heterocyclic*, Uridine/*analogs & derivatives, Humans ; Male ; Aged ; Aged, 80 and over ; Female ; Decitabine/adverse effects ; Treatment Outcome ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: Bataller A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Bazinet A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Maiti A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Jabbour EJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Yilmaz M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Takahashi K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.

المصدر: Blood advances [Blood Adv] 2024 Feb 27; Vol. 8 (4), pp. 927-935.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Proto-Oncogene Proteins p21(ras)*/therapeutic use , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics , Sulfonamides* , Bridged Bicyclo Compounds, Heterocyclic*, Humans ; Prognosis ; Retrospective Studies

المؤلفون: Rao A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Agrawal A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Battula VL; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Maiti A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA AMaiti@mdanderson.org.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Feb 27; Vol. 12 (2). Date of Electronic Publication: 2024 Feb 27.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Intraepithelial Lymphocytes*/metabolism , Leukemia, Myeloid, Acute*/therapy , Graft vs Host Disease*, Humans ; Animals ; Mice ; Receptors, Antigen, T-Cell, gamma-delta/metabolism ; Biology

المؤلفون: Senapati J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Urrutia S; Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Maiti A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Abbas HA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Chien KS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Hammond DE; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Patel K; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.

المصدر: Blood [Blood] 2023 Nov 09; Vol. 142 (19), pp. 1647-1657.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/diagnosis , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics, Humans ; Aged ; RNA Splicing Factors/genetics ; Prognosis ; Serine-Arginine Splicing Factors/genetics ; Splicing Factor U2AF/genetics ; Mutation

المؤلفون: Hammond D; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Loghavi S; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Wang SA; Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Konopleva MY; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Kadia TM; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Daver NG; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Ohanian M; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Issa GC; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Alvarado Y; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Short NJ; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Sasaki K; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Pemmaraju N; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Montalban-Bravo G; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Lachowiez CA; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Maiti A; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Jabbour EJ; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Borthakur G; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Ravandi F; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Takahashi K; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Pierce SR; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., Kantarjian HM; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA., DiNardo CD; Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. cdinardo@mdanderson.org.

المصدر: Blood cancer journal [Blood Cancer J] 2023 Sep 21; Vol. 13 (1), pp. 148. Date of Electronic Publication: 2023 Sep 21.

نوع المنشور: Letter; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Bridged Bicyclo Compounds, Heterocyclic*/pharmacology , Bridged Bicyclo Compounds, Heterocyclic*/therapeutic use , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics, Humans ; Sulfonamides/therapeutic use ; Isocitrate Dehydrogenase/genetics

المؤلفون: Cuglievan B; Division of Pediatrics, Department of Pediatric Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Bcuglievan@mdanderson.org., Connors J; Division of Pediatrics, Department of Pediatric Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., He J; Division of Pediatrics, Department of Pediatric Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Khazal S; Division of Pediatrics, Department of Pediatric Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yedururi S; Division of Radiology, Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dai J; Division of Internal Medicine, Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garces S; Division of Pathology, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Quesada AE; Division of Pathology, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Roth M; Division of Pediatrics, Department of Pediatric Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia M; Division of Pediatrics, Department of Pediatric Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McCall D; Division of Pediatrics, Department of Pediatric Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gibson A; Division of Pediatrics, Department of Pediatric Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ragoonanan D; Division of Pediatrics, Department of Pediatric Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Petropoulos D; Division of Pediatrics, Department of Pediatric Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tewari P; Division of Pediatrics, Department of Pediatric Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nunez C; Division of Pediatrics, Department of Pediatric Patient Care, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Mahadeo KM; Division of Pediatric Transplantation and Cellular Therapy, Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA., Tasian SK; Division of Oncology and Center for Childhood Cancer Research, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA, USA., Lamble AJ; Division of Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, USA., Pawlowska A; Division of Pediatric Hematology/Oncology, and Hematopoietic Stem Cell Transplantation, City of Hope, Duarte, CA, USA., Hammond D; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Maiti A; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Haddad FG; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Senapati J; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Daver N; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Gangat N; Department of Hematology, Mayo Clinic, Rochester, MN, USA., Konopleva M; Department of Oncology, Montefiore Einstein Cancer Center, Bronx, NY, USA., Meshinchi S; Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Pemmaraju N; Division of Cancer Medicine, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

المصدر: Leukemia [Leukemia] 2023 Sep; Vol. 37 (9), pp. 1767-1778. Date of Electronic Publication: 2023 Jul 14.

نوع المنشور: Journal Article; Review; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

مواضيع طبية MeSH: Hematologic Neoplasms*/pathology , Skin Neoplasms*/pathology , Hematopoietic Stem Cell Transplantation* , Myeloproliferative Disorders*/pathology, Child ; Humans ; Adolescent ; Young Adult ; Aged ; Dendritic Cells/pathology